Model
Edge
Navidea Biopharmaceuticals, Inc.
NAVB
Filing Type
DEF 14A
Filing Date
10/23/2022
Updated
10/24/22, 11:10 AM
Filing
DEF 14A
Earnings Release
Exhibits
DEF 14A
Definitive Proxy Statement